Cole Bredehoeft
banner
cbredemd.bsky.social
Cole Bredehoeft
@cbredemd.bsky.social
HIV/ID at Ohio State 🦠👨🏻‍⚕️ • MP4L via OSU Med-Peds • MU Medicine & Mizzou alum 🐯• 🏳️‍🌈 • @cbredeMD.bsky.social • Views are my own
Pinned
Finally finished with graduations!

Excited to finish ID training in a few weeks followed by some well deserved time off before joining faculty here at @OhioState_ID!

Thankful to train & learn at such a great institution and for the amazing mentorship in HIV. #IDSky #HIVSky
Infective endocarditis due to C. fetus: an opportunistic infection in a patient with AIDS | ASM Case Reports journals.asm.org/doi/10.1128/...
Infective endocarditis due to C. fetus: an opportunistic infection in a patient with AIDS | ASM Case Reports
Campylobacter fetus is a gram-negative, non-spore-forming, spiral-shaped bacterium that is composed of two humanly relevant subspecies, including C. fetus subspecies fetus and C. fetus subspecies vene...
journals.asm.org
September 10, 2025 at 10:18 PM
Finally finished with graduations!

Excited to finish ID training in a few weeks followed by some well deserved time off before joining faculty here at @OhioState_ID!

Thankful to train & learn at such a great institution and for the amazing mentorship in HIV. #IDSky #HIVSky
May 23, 2025 at 4:44 PM
So thankful for the opportunity to attend CROI for the first time and learn from so many researchers and clinicians from around the world. Excited to be joining such a great group and looking forward to attending more meetings in the future! #CROI2025
March 14, 2025 at 7:44 PM
Excited to share our abstract review featured in the AMJ Microbiology & Infectious Diseases Review of IDWeek 2024!
Breast Cancer and Colorectal Cancer Screenings Among People with HIV: The Role of Individual and System-Level Factors on Screening Completion
As persons with HIV (PWH) age, non-AIDS-defining cancers (NADC) are emerging as a leading cause of morbidity and mortality...
www.emjreviews.com
December 5, 2024 at 4:25 AM
Reposted by Cole Bredehoeft
#Skytorial #IDsky #HIVsky #IDMedEd @idsainfo.bsky.social

New HIV meds in pipeline/investigational
-MK8507 (Ulonivirine): NNRTI long half life 7-10 days, resistant profile similar to doravirine
-paired with nucleoside RT translocation inhibitor (islatravir)
November 27, 2024 at 2:47 AM
Reposted by Cole Bredehoeft